CLDX - Celldex Therapeutics Inc
Celldex Therapeutics Inc Logo

CLDX - Celldex Therapeutics Inc

https://www.celldex.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey.

52W High
$47.00
52W Low
$14.40
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.19
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-17.34
EV/Revenue (<3 favorable)
153.96
P/S (TTM) (<3 favorable)
262.30
P/B (<3 favorable)
2.32
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.19%
Institutions (25–75% balanced)
111.32%
Shares Outstanding
66,406,000
Float
53,207,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
5,790,000
Gross Profit (TTM)
-193,222,000
EPS (TTM)
-3.01
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-87.48%
ROE (TTM) (>15% strong)
-0.27%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.71
Momentum
Bearish momentum
Value
0.6797
Previous
0.6516
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025